Table 2.
Group | Baseline | 6th week | Time effect | Treatment × time interaction | Treatment effect | |||||
---|---|---|---|---|---|---|---|---|---|---|
F | P | F | P | F | P | |||||
Physical functioning | FAS | Placebo | 85.25 ± 11.53 | 87.95 ± 10.28 | 23.501 | 0.000∗ | 0.777 | 0.379 | 0.585 | 0.445 |
XPYS | 85.70 ± 12.79 | 89.60 ± 8.22 | ||||||||
PPS | Placebo | 85.25 ± 11.53 | 87.95 ± 10.28 | 23.313 | 0.000∗ | 0.844 | 0.359 | 1.110 | 0.293 | |
XPYS | 86.03 ± 12.52 | 90.00 ± 7.32 | ||||||||
| ||||||||||
Role physical | FAS | Placebo | 47.25 ± 36.39 | 53.25 ± 36.18 | 24.286 | 0.000∗ | 2.848 | 0.093 | 4.686 | 0.032∗ |
XPYS | 54.25 ± 35.90 | 66.50 ± 33.75 | ||||||||
PPS | Placebo | 47.25 ± 36.39 | 53.25 ± 36.18 | 23.950 | 0.000∗ | 2.880 | 0.091 | 5.033 | 0.026∗ | |
XPYS | 54.64 ± 36.14 | 67.01 ± 33.57 | ||||||||
| ||||||||||
Bodily pain | FAS | Placebo | 68.29 ± 14.59 | 70.65 ± 14.03 | 36.080 | 0.000∗ | 7.468 | 0.007∗ | 0.195 | 0.660 |
XPYS | 65.54 ± 13.12 | 71.84 ± 12.16 | ||||||||
PPS | Placebo | 68.29 ± 14.59 | 70.65 ± 14.03 | 36.804 | 0.000∗ | 8.025 | 0.005∗ | 0.380 | 0.538 | |
XPYS | 65.13 ± 12.83 | 71.63 ± 11.98 | ||||||||
| ||||||||||
General health | FAS | Placebo | 45.69 ± 13.66 | 47.59 ± 13.71 | 7.929 | 0.005∗ | 2.146 | 0.145 | 2.006 | 0.158 |
XPYS | 45.68 ± 16.19 | 51.70 ± 13.34 | ||||||||
PPS | Placebo | 45.69 ± 13.66 | 47.59 ± 13.71 | 8.249 | 0.005∗ | 2.370 | 0.125 | 1.475 | 0.226 | |
XPYS | 45.24 ± 16.03 | 51.53 ± 13.21 | ||||||||
| ||||||||||
Vitality | FAS | Placebo | 50.05 ± 13.46 | 53.55 ± 14.71 | 27.812 | 0.000∗ | 1.164 | 0.282 | 1.671 | 0.198 |
XPYS | 51.60 ± 15.17 | 56.90 ± 15.17 | ||||||||
PPS | Placebo | 50.05 ± 13.46 | 53.55 ± 14.71 | 28.076 | 0.000∗ | 1.348 | 0.247 | 1.355 | 0.246 | |
XPYS | 51.29 ± 15.14 | 56.75 ± 15.23 | ||||||||
| ||||||||||
Social functioning | FAS | Placebo | 70.75 ± 17.70 | 72.38 ± 15.82 | 10.143 | 0.002∗ | 2.235 | 0.137 | 1.867 | 0.173 |
XPYS | 72.13 ± 16.17 | 76.63 ± 14.40 | ||||||||
PPS | Placebo | 70.75 ± 17.70 | 72.38 ± 15.82 | 9.898 | 0.002∗ | 2.189 | 0.141 | 2.264 | 0.134 | |
XPYS | 72.42 ± 16.23 | 76.93 ± 14.25 | ||||||||
| ||||||||||
Role emotional | FAS | Placebo | 47.00 ± 35.17 | 55.33 ± 33.58 | 21.020 | 0.000∗ | 0.115 | 0.735 | 2.002 | 0.159 |
XPYS | 52.33 ± 33.59 | 62.00 ± 29.60 | ||||||||
PPS | Placebo | 47.00 ± 35.17 | 55.33 ± 33.58 | 20.385 | 0.000∗ | 0.105 | 0.746 | 2.136 | 0.146 | |
XPYS | 52.58 ± 33.62 | 62.20 ± 29.12 | ||||||||
| ||||||||||
Mental health | FAS | Placebo | 54.96 ± 14.54 | 57.64 ± 14.64 | 8.009 | 0.005∗ | 3.024 | 0.084 | 0.172 | 0.679 |
XPYS | 56.76 ± 13.41 | 57.40 ± 13.04 | ||||||||
PPS | Placebo | 54.96 ± 14.54 | 57.64 ± 14.64 | 7.861 | 0.006∗ | 2.876 | 0.091 | 0.291 | 0.590 | |
XPYS | 56.99 ± 13.38 | 57.65 ± 12.98 |